These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

203 related items for PubMed ID: 21098110

  • 1. OnabotulinumtoxinA for the treatment of chronic migraine not quite there. .
    Torgovnick J.
    Cephalalgia; 2011 Feb; 31(3):377; author reply 378-9. PubMed ID: 21098110
    [No Abstract] [Full Text] [Related]

  • 2. Botulinum toxin for chronic migraine.
    Med Lett Drugs Ther; 2011 Jan 24; 53(1356):7-8. PubMed ID: 21252842
    [No Abstract] [Full Text] [Related]

  • 3. OnabotulinumtoxinA for treatment of chronic migraine: a response.
    Dodick DW, Turkel CC, Degryse RE, Aurora SK, Silberstein SD, Lipton RB, Diener HC, Brin MF.
    Headache; 2011 Jun 24; 51(6):1005-8. PubMed ID: 21592099
    [No Abstract] [Full Text] [Related]

  • 4. OnabotulinumtoxinA for treatment of chronic migraine: the unblinding problem.
    Solomon S.
    Headache; 2013 May 24; 53(5):824-6. PubMed ID: 23465058
    [No Abstract] [Full Text] [Related]

  • 5. OnabotulinumtoxinA for chronic migraine.
    Blumenfeld A, Evans RW.
    Headache; 2012 Jan 24; 52(1):142-8. PubMed ID: 22268776
    [No Abstract] [Full Text] [Related]

  • 6. OnabotulinumtoxinA for chronic migraine: a real-life Italian multicenter experience.
    Vernieri F, Paolucci M, Altamura C, Pasqualetti P, Mastrangelo V, Pierangeli G, Cevoli S, D'Amico D, Grazzi L.
    Neurol Sci; 2018 Jun 24; 39(Suppl 1):171-172. PubMed ID: 29904838
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. OnabotulinumtoxinA in chronic migraine: long-term efficacy in a prophylactic medication free cohort.
    Schiano di Cola F, Pari E, Caratozzolo S, Mancinelli C, Liberini P, Rao R, Padovani A.
    Neurol Sci; 2018 Jun 24; 39(Suppl 1):159-160. PubMed ID: 29904848
    [No Abstract] [Full Text] [Related]

  • 9. Botulinum toxin type A for the treatment of migraine.
    Aurora S.
    Expert Opin Pharmacother; 2006 Jun 24; 7(8):1085-95. PubMed ID: 16722818
    [Abstract] [Full Text] [Related]

  • 10. Chronic migraine: a therapeutic challenge for clinicians.
    Irimia P, Carmona-Abellán M, Martínez-Vila E.
    Expert Opin Emerg Drugs; 2012 Dec 24; 17(4):445-7. PubMed ID: 22998764
    [Abstract] [Full Text] [Related]

  • 11. OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial.
    Diener HC, Dodick DW, Aurora SK, Turkel CC, DeGryse RE, Lipton RB, Silberstein SD, Brin MF, PREEMPT 2 Chronic Migraine Study Group.
    Cephalalgia; 2010 Jul 24; 30(7):804-14. PubMed ID: 20647171
    [Abstract] [Full Text] [Related]

  • 12. OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial.
    Aurora SK, Dodick DW, Turkel CC, DeGryse RE, Silberstein SD, Lipton RB, Diener HC, Brin MF, PREEMPT 1 Chronic Migraine Study Group.
    Cephalalgia; 2010 Jul 24; 30(7):793-803. PubMed ID: 20647170
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Botulinum toxin A and migraine surgery.
    Guyuron B, Tucker T, Kriegler J.
    Plast Reconstr Surg; 2003 Oct 24; 112(5 Suppl):171S-173S; discussion 174S-176S. PubMed ID: 14504501
    [No Abstract] [Full Text] [Related]

  • 15. OnabotulinumtoxinA (BOTOX®): a guide to its use in preventing headaches in adults with chronic migraine.
    Lyseng-Williamson KA, Frampton JE.
    CNS Drugs; 2012 Aug 01; 26(8):717-23. PubMed ID: 22784019
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Onabotulinumtoxin [corrected] A (Botox).
    Tepper D.
    Headache; 2014 Apr 01; 54(4):787-8. PubMed ID: 24697235
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. OnabotulinumtoxinA improves quality of life and reduces impact of chronic migraine over one year of treatment: Pooled results from the PREEMPT randomized clinical trial program.
    Lipton RB, Rosen NL, Ailani J, DeGryse RE, Gillard PJ, Varon SF.
    Cephalalgia; 2016 Aug 01; 36(9):899-908. PubMed ID: 27288354
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.